CLINICAL TRIAL

Osteopathic Manipulative Treatment (OMT) for COVID-19

Recruiting · 18+ · All Sexes · Pomona, CA

This study is evaluating whether Osteopathic Manipulative Treatment (OMT) procedures can enhance the immune response to a vaccine.

See full description

About the trial for COVID-19

Eligible Conditions
COVID-19 · Covid19

Treatment Groups

This trial involves 2 different treatments. Osteopathic Manipulative Treatment (OMT) is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Osteopathic Manipulative Treatment (OMT)
OTHER
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.

Eligibility

This trial is for patients born any sex aged 18 and older. There are 4 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
I will be receiving the mRNA COVID-19 vaccine at Western University of Health Sciences. show original
Are 18 to 65 years old. show original
Have signed an informed consent form
I have not previously received a COVID-19 vaccine. show original
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: Through study completion, an average of 1 year
Screening: ~3 weeks
Treatment: Varies
Reporting: Through study completion, an average of 1 year
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: Through study completion, an average of 1 year.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Osteopathic Manipulative Treatment (OMT) will improve 3 primary outcomes and 2 secondary outcomes in patients with COVID-19. Measurement will happen over the course of At 3 months, 6 months and 1 year post- vaccination..

IgM and IgG antibody titer duration
AT 3 MONTHS, 6 MONTHS AND 1 YEAR POST- VACCINATION.
Time in days in which levels of IgM and IgG assay remain above detectable levels in subjects receiving control treatment (no OMT) vs subjects receiving intervention treatment (OMT) after vaccination.
AT 3 MONTHS, 6 MONTHS AND 1 YEAR POST- VACCINATION.
IgM antibody titer levels Percentage Change.
AT 1 WEEK, 3 WEEKS, 4 WEEKS, 5 WEEKS, 3 MONTHS, 6 MONTHS AND 1 YEAR POST- VACCINATION.
Percentage change from baseline in IgM assay levels of pre-vaccination titer vs IgM assay levels in subjects receiving control treatment (no OMT) vs subjects receiving intervention treatment (OMT).
AT 1 WEEK, 3 WEEKS, 4 WEEKS, 5 WEEKS, 3 MONTHS, 6 MONTHS AND 1 YEAR POST- VACCINATION.
IgG antibody titer levels Percentage Change
AT 1 WEEK, 3 WEEKS, 4 WEEKS, 5 WEEKS, 3 MONTHS, 6 MONTHS AND 1 YEAR POST- VACCINATION.
Percentage change from baseline in IgG assay levels of pre-vaccination titer vs IgG assay levels in subjects receiving control treatment (no OMT) vs subjects receiving intervention treatment (OMT).
AT 1 WEEK, 3 WEEKS, 4 WEEKS, 5 WEEKS, 3 MONTHS, 6 MONTHS AND 1 YEAR POST- VACCINATION.
Adverse Effects/Side Effects
THROUGH STUDY COMPLETION, AN AVERAGE OF 1 YEAR
Reported side effects from the vaccines or adverse effects experienced from OMT.
THROUGH STUDY COMPLETION, AN AVERAGE OF 1 YEAR
Medication Usage
THROUGH STUDY COMPLETION, AN AVERAGE OF 1 YEAR
Assessment of medications that subjects used to negate side effects using a medication log.
THROUGH STUDY COMPLETION, AN AVERAGE OF 1 YEAR

Who is running the study

Principal Investigator
J. S.
Prof. Jesus Sanchez, Professor of Family Medicine
Western University of Health Sciences

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people get covid-19 a year in the United States?

Each year, around 11,000–33,000 Americans develop a case of covid-19, and 2,000–8,000 will die from complications from the illness. Although most Americans have been exposed to a case of covid-19 or have been in contact with an ill person who had covid-19, only 3% of Americans have been hospitalised with the disease.

Anonymous Patient Answer

Can covid-19 be cured?

In a recent study, findings found that a low and safe initial dose of the antiviral drug remdesivir in patients who had not received immune suppression or high doses of steroids had improved survival, in terms of overall survival, in patients with severe pneumonia and no major complications. This treatment would be especially suitable with patients with previous medical history of asthma and chronic lung diseases because patients with mild symptoms, those under immunosuppressive therapy or with a mild form of pneumonia have a high level of mortality due to virus-associated pneumonia. Further evaluations are needed to clarify this issue.

Anonymous Patient Answer

What are the signs of covid-19?

Fever, cough and shortness of breath are common symptoms of coronavirus, also referred to as COVID-19.. Symptoms of COVID-19 are vague and there are no specific symptoms of it. A combination of persistent fever, cough and shortness of breath can be an indication of either the initial or secondary stages of COVID-19.

Anonymous Patient Answer

What is covid-19?

Covid-19 is an infectious disease caused by the SARS-CoV. It is a type of coronavirus – which means that it belongs to group 2 of the coronaviruses, which are also the cause of respiratory disease known as the common cold, and have an incubation period of 2–14 days. The virus spreads easily from person to person and appears to be contagious; however, it is not yet clear whether transmission is passed through the air or via direct contact. Most cases so far reported are mild and resolve without clinical treatment, while the virus causes some severe respiratory diseases in some cases. There were more than one hundred million cases reported by end of February 2020.

Anonymous Patient Answer

What are common treatments for covid-19?

Covid-19 cases in Hong Kong are treated using a variety of therapies, including non antiviral medicines and antipyretics, such as acetaminophen, ibuprofen, and paracetamol/non-acetaminophen combinations. Antiviral medicines such as TKM-101, L-arabinofuranosyladenine, remdesivir, abacavir and ribavirin are frequently prescribed to severe cases. Antibiotic therapy such as moenomycin is used for severe cases to prevent pneumonia. These therapies are complemented with supportive care. Further studies are anticipated to further explore their effectiveness and to identify the best combination of treatments to treat severe coronavirus pneumonia.

Anonymous Patient Answer

What causes covid-19?

We provide evidence that a virus has a role in the development of covid-19. More work is needed to understand this viral causation factor, although further research may show that some viruses, or antibodies created by the body to protect against infection, are the cause. More research is needed to identify whether the virus itself can cause or be transmitted in a disease-carrying manner.

Anonymous Patient Answer

Have there been other clinical trials involving osteopathic manipulative treatment (omt)?

The literature review provides a comprehensive overview of the evidence regarding the safety and efficacy to osteopathic treatments in people over a wide range of conditions including arthritis, trauma, infection, orthopaedics and sports medicine. These treatments are now routinely used to treat disease. OMT is now accepted as a vital part of the multidisciplinary approach to addressing musculoskeletal injury. The findings reported by these trials indicate that osteopathic treatments can have a beneficial effect in people with all types of musculoskeletal conditions.

Anonymous Patient Answer

What is osteopathic manipulative treatment (omt)?

This review provides the first overview of studies reporting on the use of ompt and on the efficacy and acceptance of ompt in pediatric and adolescent patients. This review provides a baseline framework for discussion of clinical practice guidelines for the treatment of pediatric OMT that may help guide future research.

Anonymous Patient Answer

What is the latest research for covid-19?

To keep yourself informed about the latest research for the disease, visit a credible resource: [National Institute on Aging/National Library of Medicine/National Institutes of Health (NIH/LID)/University of Minnesota]{http://www.nio.gov/news/covid19/research?p1=research&p2=research/covid-19_research}.

Anonymous Patient Answer

What are the common side effects of osteopathic manipulative treatment (omt)?

These side effects are similar to those reported with other forms of medical treatments. However, to a few degrees, the risks are likely overestimated. We should not delay referral to an osteopathic physician in those cases when one is warranted.

Anonymous Patient Answer

Has osteopathic manipulative treatment (omt) proven to be more effective than a placebo?

Results from a recent clinical trial supports the idea of treating patients with spinal conditions through the use of OMT. Results from a recent clinical trial imply that for an effective treatment option, the patient's medical history and symptom presentation is paramount.

Anonymous Patient Answer

What does osteopathic manipulative treatment (omt) usually treat?

OM treatment is frequently effective in a diverse range of conditions including osteoarthritis, pain, musculoskeletal stiffness, frozen shoulder, rheumatoid arthritis and even psoriasis. OM treatment is generally well tolerated and usually adds little to the cost or length of a visit.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for COVID-19 by sharing your contact details with the study coordinator.